1. Bai, Yun, Wang, Jia, Han, Jing, Qi, Wei, Jiang, Hui-Qing. 2016. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo. In Molecular carcinogenesis, 56, 1137-1149. doi:10.1002/mc.22580. https://pubmed.ncbi.nlm.nih.gov/27770580/
2. Liu, Yong, Xin, Jing, Zhang, Shengnan, Wang, Hongcheng, Li, Wenyong. 2022. Expression patterns and biological function of BCL2L10 during mouse preimplantation development. In Gene expression patterns : GEP, 46, 119285. doi:10.1016/j.gep.2022.119285. https://pubmed.ncbi.nlm.nih.gov/36341977/
3. Lee, Su-Yeon, Kwon, Jinie, Woo, Ji Hye, Kim, Kyeoung-Hwa, Lee, Kyung-Ah. 2019. Bcl2l10 mediates the proliferation, invasion and migration of ovarian cancer cells. In International journal of oncology, 56, 618-629. doi:10.3892/ijo.2019.4949. https://pubmed.ncbi.nlm.nih.gov/31894274/
4. Fabiani, Emiliano, Leone, Giuseppe, Giachelia, Manuela, Hohaus, Stefan, Voso, Maria Teresa. 2010. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. In Leukemia & lymphoma, 51, 2275-84. doi:10.3109/10428194.2010.528093. https://pubmed.ncbi.nlm.nih.gov/21077739/
5. Lee, Su-Yeon, Kwon, Jinie, Lee, Kyung-Ah. 2021. Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and IDH1. In Oncology reports, 45, . doi:10.3892/or.2021.7998. https://pubmed.ncbi.nlm.nih.gov/33649794/
6. Xu, Jing Da, Cao, Xi Xi, Long, Zi Wen, Sasaki, Kohsuke, Li, Qing Quan. 2010. BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells. In The Journal of pathology, 223, 400-9. doi:10.1002/path.2811. https://pubmed.ncbi.nlm.nih.gov/21171085/
7. Cluzeau, Thomas, Robert, Guillaume, Mounier, Nicolas, Luciano, Frederic, Auberger, Patrick. . BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients. In Oncotarget, 3, 490-501. doi:. https://pubmed.ncbi.nlm.nih.gov/22577154/
智鼠故事 
